Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy

Introduction: Small-cell-lung-cancer (SCLC) has the worst prognosis of all lung cancers because of a high incidence of relapse after therapy. While lung cancer is the second most common malignancy in the US, only about 10% of cases of lung cancer are SCLC, therefore, it is categorized as a rare and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Chandani, Koloff, Caroline R., Kundu, Souvik, Wilkinson, Dan C., Yang, Juliette M., Shia, David W., Meneses, Luisa K., Rickabaugh, Tammy M., Gomperts, Brigitte N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441219/
https://www.ncbi.nlm.nih.gov/pubmed/37608896
http://dx.doi.org/10.3389/fphar.2023.1211026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441219/
https://www.ncbi.nlm.nih.gov/pubmed/37608896
http://dx.doi.org/10.3389/fphar.2023.1211026

Ejemplares similares